Cargando…
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
Autores principales: | Cheng, Fangling, Zhang, Po, Xiao, Qungen, Li, Youwei, Dong, Minhai, Wang, Heping, Kuang, Dong, He, Yue, Duan, Qiuhong, Mao, Feng, Wang, Baofeng, Guo, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545906/ https://www.ncbi.nlm.nih.gov/pubmed/33102241 http://dx.doi.org/10.3389/fonc.2020.591112 |
Ejemplares similares
-
The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019) -
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
por: Xiao, Qungen, et al.
Publicado: (2018) -
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
por: Xiao, Qungen, et al.
Publicado: (2019) -
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
por: Xiao, Qungen, et al.
Publicado: (2022) -
LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma
por: Peng, Chenghao, et al.
Publicado: (2021)